Mexico City, October 30, 2024. In a ceremony marked by the commitment to academic excellence and innovation in the health sector, the Universidad Panamericana and the pharmaceutical company Eli Lilly and the pharmaceutical company Eli Lilly formalized a general collaboration agreement that will allow both institutions to strengthen their ties and promote joint research for the benefit of Mexican society.
The main objective of this agreement is the implementation of implementation of academic, technological development and innovation projects that reflect the commitment of both institutions to the advancement of science and education in the country.The main objective of this agreement is to implement projects of an academic, technological development and innovation nature that reflect the commitment of both institutions to the advancement of science and education in the country.
The event was held at Panamericana's Mexico City campus and was attended by important representatives from both institutions. Panamericana was represented by Dr. Santiago García Álvarezrector of the Mexico City campus; Mtro. Salvador Beltrán del RíoDirector of Institutional Development; and Almudena Vaca RomeroDirector of Postgraduate Strategy, Development and Quality.
On behalf of Eli Lilly, the following were present Perla Aceves RomeroDirector of Compensation, Benefits and Operations of Human Resources in Mexico; and the MBA Rubén Ortiz VázquezExecutive Director of Access and Corporate Affairs for Latin America.
Strategic alliances
Perla Aceves Romero highlighted the importance of this agreement as a key tool to open opportunities in the academic and research fields. opportunities in the academic and research fields, emphasizing the shared values between Eli Lilly andemphasizing the shared values between Eli Lilly and Universidad Panamericana.
"Today we signed an agreement that represents the beginning of virtuous circles for both institutions. the beginning of virtuous circles for both institutions..... Our mission at Eli Lilly is to develop innovative solutions that improve people's lives, and to do so, we need strategic allies. We found in Panamericana an institution that shares our ethics, excellence and focus on the care of the person."said Ms. Aceves.
Dr. Santiago García Álvarez emphasized the interest of Universidad Panamericana in establishing strategic alliances with the private sector. strategic alliances with the private sectorsector, emphasizing that this collaboration will allow the university to strengthen its role as an agent of change in the development of the country. agent of change in the development of the country.
"We are convinced of the important role that universities, companies and society play in the development of Mexico. This alliance with Eli Lillya company of prestige and global relevance, will allow Panamericana to increase its contributions in corporate chairs, masterclasses and research that will impact our students and, therefore, society as a whole."said the rector.
Objectives and scope of the agreement
This agreement between Eli Lilly and Panamericana establishes a solid collaboration that goes beyond academia, encompassing applied research projects and technological development that may result in significant innovations for the health sector. applied research and technological development projects that may result in significant innovations for the health sector..
Areas of collaboration will include corporate lectureships, masterclasses and masterclasses and the participation of students in internship programs at Eli Lilly, allowing students from our university to gain direct experience in a leading pharmaceutical company. to gain direct experience in a leading pharmaceutical company.
In addition, this agreement is part of Panamericana's long-term vision to strengthen the link between academia and industry. Salvador Beltran del Rio emphasized that. "Panamericana is committed to creating spaces where students can interact with high-level professionals and receive a comprehensive education that encompasses not only theoretical knowledge, but also practical application in business and research environments.".
Innovation and social commitment
Eli Lilly, founded nearly 150 years ago, is known worldwide for its recognized worldwide for its commitment to innovation and the development of medicines that enable people to live healthier and more active lives. In Mexico, the company has been present for 81 years and continues to be a benchmark in the pharmaceutical industry.
The collaboration with Universidad Panamericana represents an opportunity for Lilly to actively contribute to the training of talented young people. opportunity to actively contribute to the training of talented young people who can contribute to scientific progress and social welfare. who will be able to contribute to scientific progress and social welfare.
Panamericana, on the other hand, has an outstanding track record in research and a strong focus on health sciences. This agreement opens the door for both institutions to work together on research and patent development projects, with the possibility of transferring these innovations to the market, thus generating a positive impact on the lives of people.with the possibility of transferring these innovations to the market, thus generating a positive impact on people's lives.
A promising future for Mexico
At the end of the event, Dr. García Álvarez emphasized that this collaboration with Eli Lilly is an example of the "triple helix". "triple helix" (the collaboration between (the collaboration between university, business and government) which seeks to to promote projects with social and economic impact at a national level..
"Many times what universities and companies do has a significant weight on the progress of a country. We are very pleased to sign this agreement with Eli Lilly and we are confident that together we will contribute to the development of Mexico, especially in the field of health, a sector with great potential for the future."concluded the rector.
The signing of the agreement was received with enthusiasm by both institutions, which reaffirmed their commitment to continue working together for the benefit of society. to continue working together for the benefit of society.. With this agreement, Eli Lilly and the Universidad Panamericana demonstrate that collaboration between academia and industry is fundamental to face the challenges of the futureThe agreement will contribute to the development of innovative solutions that transform social reality and promote a healthier and more educated Mexico.
Learn more about Universidad Panamericana at: https://www.up.edu.mx/sobre-la-universidad-fundamentos-y-valores/
